If you are curious about how your brain really works this is the podcast for you! Hosted by physician Dr. Ginger Campbell (2022 Podcast Hall of Fame) from 2006-2023, Brain Science explores how recent discoveries in neuroscience are unraveling the mystery of how our brain makes us human. It features conversations with leading scientists and philosophers and is "the podcast for everyone who has a brain" because Dr. Campbell makes neuroscience accessible to listeners of all backgrounds. Over 10 ...
…
continue reading
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment
MP3•Episode home
Manage episode 324614161 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will break down what the community physician needs to know about this emerging therapy as it makes it’s way out of clinical trials and into the clinic.
Featuring:
Omid Hamid, MD
Cedars-Sinai CANCER
Los Angeles, CA
44 episodes
MP3•Episode home
Manage episode 324614161 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will break down what the community physician needs to know about this emerging therapy as it makes it’s way out of clinical trials and into the clinic.
Featuring:
Omid Hamid, MD
Cedars-Sinai CANCER
Los Angeles, CA
44 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.